Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 2 Pulmonary Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02279160
What this trial is testing

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 61
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Testing effectiveness (Phase 2)Study completedNCT04456998
What this trial is testing

GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Artery Hypertension
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 86
Not applicableStudy completedNCT06350773
What this trial is testing

Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension

Who this might be right for
Group 2 Pulmonary HypertensionCpcPH
Beni-Suef University 66
Testing effectiveness (Phase 2)Study completedNCT02664558
What this trial is testing

Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 61
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Testing effectiveness (Phase 2)Ended earlyNCT02736149
What this trial is testing

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 51
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Study completedNCT00414687
What this trial is testing

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 63
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Testing effectiveness (Phase 2)WithdrawnNCT04882774
What this trial is testing

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Mardi Gomberg -Maitland MD, MSc
Early research (Phase 1)Study completedNCT03754660
What this trial is testing

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Who this might be right for
Hypertension, Pulmonary
Bayer 38
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc